NeuroMetrix, Inc. (NASDAQ:NURO)

CAPS Rating: No stars

The Company designs, develops and sells proprietary medical devices used to help physicians diagnose neuropathies and neurovascular disease.

Recs

0
Player Avatar mnsmartmoney (23.26) Submitted: 3/8/2007 6:52:17 PM : Outperform Start Price: $11.86 NURO Score: -90.58

This one is way oversold and due for some good news. IMO they look like they could be bought out with where the price is now. From my own dd I see their products as viable and legitimate. I look for the whole reimbursement problem to resolve itself. Like they say "Buy when there is blood on the streets". Now is the time to jump in on this one.

Featured Broker Partners


Advertisement